[Essential thrombocythemia: antiaggregants].
Cortelazzo
S
S
Divisione di Ematologia, Ospedali Riuniti di Bergamo.
Barbui
T
T
D000328:Adult; D000368:Aged; D015331:Cohort Studies; D006470:Hemorrhage / Q000453:epidemiology / Q000209:etiology; D006801:Humans; D015994:Incidence; D008875:Middle Aged; D010975:Platelet Aggregation Inhibitors / Q000008:administration & dosage / Q000627:therapeutic use*; D011087:Polycythemia Vera / Q000150:complications / Q000188:drug therapy; D012189:Retrospective Studies; D012307:Risk Factors; D013920:Thrombocythemia, Essential / Q000150:complications / Q000188:drug therapy*; D013923:Thromboembolism / Q000453:epidemiology / Q000209:etiology / Q000517:prevention & control
D010975:Platelet Aggregation Inhibitors
Trombocitemia essenziale: gli antiaggreganti.